Speakers

Keynote Speakers

2019 Schneerson-Robbins Prize Awardee
Kathryn M. Edwards

Director, Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine, USA

Kathryn M. Edwards, MD is the Sarah H. Sell and Cornelius Vanderbilt Professor of Pediatrics. Dr. Edwards joined the Vanderbilt Vaccine Program in 1980 and has conducted many pivotal vaccine studies since that time.

View full bio

2019 Edward Jenner Lifetime Achievement Awardee
Rino Rappuoli

Chief Scientist & Head of External Research and Development, GlaxoSmithKline Vaccines, USA

Rino Rappuoli is Chief Scientist and Head External R&D at GSK Vaccines, based in Siena, Italy and Professor at Imperial College. Prior positions: head of Vaccine R&D at Novartis, CSO of Chiron Corporation, head for R&D at Sclavo.

View full bio

Invited Speakers

Sean Bennett

Emergent Biosolutions, USA

Talk Tile: Continued Progress in the Development of a Single-Dose VLP-Based Chikungunya Vaccine

Dr. Bennett is currently Senior Director, Clinical Development at Emergent Biosolutions Inc., a multinational specialty biopharmaceutical company headquartered near Washington DC (USA).

View full bio

Niranjan Bhat

Center for Vaccine Innovation and Access PATH, USA

Niranjan Bhat, MD, MHS, is a Senior Medical Officer within the Center for Vaccine Innovation and Access at PATH, currently leading strategy for post-licensure vaccine clinical research.Having received undergraduate and medical education at Harvard and Vanderbilt Universities, respectively, Dr. Bhat completed residency in pediatrics at the University of Washington, Seattle.

View full bio

Aaron Esser-Kahn

University of Chicago, USA

Aaron was born and raised in Bloomfield Hills, MI. He attended the Cranbrook educational community from grades K-12.

View full bio

Helen Fletcher

London School of Hygiene & Tropical Medicine (LSHTM), UK

Helen Fletcher is a Professor of Immunology at the London School of Hygiene & Tropical Medicine (LSHTM) and Director of International Development, UKRI.

View full bio

Vanessa Harris

Amsterdam UMC, University of Amsterdam, Netherlands

View full bio

Ivan Hung

Hong Kong University, Hong Kong

Professor Ivan Fan Ngai HUNG is currently Ru Chien and Helen Lieh Endowed Professor in Health Sciences Pedagogy, Clinical Professor and Assistant Dean (Admissions), Chief of the Division of Infectious Diseases, Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, and Honorary Consultant in Queen Mary Hospital, Hong Kong.

View full bio

Ken Ishii

The University of Tokyo, Japan

Ken Ishii is currently appointed as Director for Vaccine and Adjuvant Research Center (CVAR) at National Institutes for Biomedical Innovation, Health and Nutrition (NIBIOHN) as well as Professor at the Laboratory of Vaccine Science at the Immunology Frontier Research Center (IFREC) of Osaka University in Japan.

View full bio

Hajime Kamiya

National Institute of Infectious Disease (NIID), Japan

View full bio

Nichole Klatt

University of Miami, USA

Dr. Nichole Klatt is an associate professor, vice chair of research, and the Adrienne Arsht Endowed Chair in Pediatric clinical research in the Department of Pediatrics, Miller School of Medicine, and Sylvester Cancer Center of University of Miami. Prior to this,

View full bio

Jean Lim

Icahn School of Medicine at Mount Sinai, USA

Dr. Lim received her Ph.D. In Microbiology and Immunology from the University of Maryland and completed her post doctoral training in the Laboratory of Molecular Immunology at the National Institutes of Health.

View full bio

Helena Maltezou

Hellenic Center for Disease Control and Prevention, Athens, Greece

Dr. Maltezou received her Medical Diploma and her PhD from the University of Crete, Greece, and had her post-doctoral fellowship during 1994-1997 on viral infections in immunocompromised patients at M.D. Anderson Cancer Center, Houston. During 1997-2001 Dr Maltezou was trained at the Pediatric Residency Program of the University of Athens, Greece, and during 2001-2003 in Infectious Diseases at the Universite de la Mediterannee, Marseille, France.

View full bio

Imraan Munshi

Merck, USA

Imraan Munshi is Global Communications Lead – Vaccines for MSD leading the development and implementation of global communications strategies and programs in support of the Company’s vaccine brands, portfolios and investigational vaccines.

View full bio

Jen Nelson

Kaiser Permanente

Director of Biostatistics & Senior Investigator
Biostatistics Unit, Kaiser Permanente Washington Health Research Institute
Affiliate Professor, Department of Biostatistics, University of Washington

View full bio

Eng Eong Ooi

Duke-NUS Medical School, Singapore

View full bio

Mark Orr

Infectious Disease Research Institute, USA

Mark Orr is Senior Scientist at the Infectious Disease Research Institute, Vice-President of Immunology at HDT Bio Corp, and Affiliate Assistant Professor of Global Health at the University of Washington.

View full bio

Yong Poovorawan

Chulalongkorn University, Thailand

Talk Title: Elimination of hepatitis by the year 2030; role of hepatitis vaccines

Prof. Yong Poovorawan is currently Head of the Center of Excellence in Clinical Virology at the Faculty of Medicine, Chulalongkorn University, Bangkok.

View full bio

Alexandra Schuetz

US Army Medical Component of the Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand

View full bio

Julia Spencer

Merck, USA

Julia Spencer serves as the Associate Vice President, Global Vaccines Public Policy, Partnerships, and Government Affairs at MSD. In this role, she leads global public policy and advocacy to expand access to MSD vaccines, and develops and guides policy strategy and tactical implementation programs to achieve maximum population health impact and business growth.

View full bio

Kanta Subbarao

WHO Melbourne, Australia

Dr. Kanta Subbarao is the Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity and Professor, Department of Microbiology and Immunology, The University of Melbourne. She is a virologist and a physician with specialty training in pediatrics and pediatric infectious diseases.

View full bio

Usa Thisyakorn

Chulalongkorn University, Thailand

Professor Usa Thisyakorn is presently a Professor of Pediatrics and an Executive Director of Tropical Medicine Cluster at Chulalongkorn University, an advisor of Faculty of Tropical Medicine, Mahidol University, Department of Health, Bangkok Metropolitan Administration and Faculty of Medicine, Thammasat University.

View full bio

Drew Weissman

University of Pennsylvania, USA

Drew Weissman received his M.D. and Ph.D. in microbiology from Boston University, Boston, MA. He completed an Internal Medicine residency at the Beth Israel Hospital in Boston and a fellowship in Allergy/Immunology at the NIH.

View full bio

Spotlight on Asia Speakers

Ken Ishii

The University of Tokyo, Japan

Ken Ishii is currently appointed as Director for Vaccine and Adjuvant Research Center (CVAR) at National Institutes for Biomedical Innovation, Health and Nutrition (NIBIOHN) as well as Professor at the Laboratory of Vaccine Science at the Immunology Frontier Research Center (IFREC) of Osaka University in Japan.

View full bio

Chutitorn Ketloy

Chula Vaccine Research Center, Chulalongkorn University, Thailand

View full bio

Suchinda Malaivijitnond

Chulalongkorn University, Bangkok, Thailand

Dr. Malaivijitnond is a professor at the Department of Biology, Faculty of Science, Chualongkorn University. The area of her expertise is non-human primates with two topics of interest; reproductive physiology and biodiversity. For the first approach, her focus is on the effects of Pueraria mirifica phytoestrogens on reproductive organs, osteoporosis and Alzheimer’s disease tested in laboratory animals.

View full bio

Dorothy Ng

Duke-NUS Medical School and Singapore General Hospital, Singapore

View full bio

Kanitha Patarakul

Chula Vaccine Research Center, Chulalongkorn University, Thailand

View full bio

Sapna Sadarangani

National Centre for Infectious Diseases (NCID), Singapore

Talk Title: Evaluation of metabolic predictors of influenza vaccine immune response in Singapore’s elderly population: the DYNAMIC trial

Dr. Sapna Sadarangani is Infectious Diseases Consultant at the National Centre for Infectious Diseases (NCID), Singapore and co-chair of Singapore’s Paediatric, Obstetric & Neonatal outbreak- preparedness workgroup. Dr. Sadarangani received her medical training (MBBS) at the Yong Loo Lin School of Medicine, National University of Singapore.

View full bio

Yasuhiro Yasutomi

National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Japan

Dr. Yasuhiro Yasutomi DVM, Ph.D. is an immunologist in vaccine development field. He was an Instructor in Harvard Medical School from 1992-1994.

View full bio